𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease

✍ Scribed by M. Tangney; G. Casey; J. O. Larkin; C. G. Collins; D. Soden; J. Cashman; M. C. Whelan; G. C. O’Sullivan

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
262 KB
Volume
55
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer gene therapy with HSV-tk/GCV syst
Cancer gene therapy with HSV-tk/GCV system depends on t-cell-mediated immune responses and causes apoptotic death of tumor cells In vivo
✍ Shigeki Kuriyama; Masaji Kikukawa; Kazuhiro Masui; Hirotsugu Okuda; Toshiya Naka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

To examine the immunological mechanisms involved in cancer gene therapy using the herpes simplex virus thymidine kinase (HSV-tk) gene and ganciclovir (GCV), murine hepatocellular carcinoma (HCC) cells, BNL1ME A.7R.1, were transduced retrovirally with the HSV-tk gene. HSV-tk-transduced cells exhibite

Controlled systemic release of interleuk
Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas
✍ Gregor Tevz; Simona Kranjc; Maja Cemazar; Urska Kamensek; Andrej Coer; Mojca Krz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

## Abstract ## Background The present study aimed to evaluate the antitumor effectiveness of systemic __interleukin (IL)‐12__ gene therapy in murine sarcoma models, and to evaluate its interaction with the irradiation of tumors and metastases. To avoid toxic side‐effects of __IL‐12__ gene therapy,